Healthcare Sector

SLRN

Market Tracker

$5.40
-0.05
(-0.92%)
12:20 am
Next Earnings: (est.) n/a
  • SLRN (Selected)

    ACELYRIN, INC.

SLRN Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

SLRN Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

SLRN Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

SLRN Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

SLRN Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

SLRN Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
10/18/2024 CALL $5.00 245 +101 +70.14%
10/18/2024 CALL $2.50 1 0
10/18/2024 CALL $7.50 92 0
10/18/2024 CALL $10.00 0 0
10/18/2024 PUT $2.50 20 0
10/18/2024 PUT $5.00 533 0
05/16/2025 CALL $7.50 0 0
05/16/2025 CALL $10.00 0 0
05/16/2025 PUT $2.50 0 0
05/16/2025 PUT $5.00 0 0
05/16/2025 PUT $7.50 0 0
05/16/2025 PUT $10.00 0 0

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

SLRN News

  • Thyroid Eye Disease Market to Accelerate Substantially by 2034, Assesses DelveInsight | Key Companies Developing ... - GlobeNewswire

    07/04 04:01 pm

    GlobeNewswire Inc.

    Read more
  • ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones

    05/09 08:01 am

    GlobeNewswire Inc.

    Read more
  • ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024

    04/29 04:05 pm

    GlobeNewswire Inc.

    Read more
  • ACELYRIN (SLRN) Up on Data From Thyroid Eye Disease Study

    03/21 11:12 am

    Zacks Investment Research

    Read more
  • ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis

    03/11 08:02 am

    GlobeNewswire Inc.

    Read more
  • ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications

    02/15 05:05 pm

    GlobeNewswire Inc.

    Read more
  • ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors

    12/20 05:30 pm

    GlobeNewswire Inc.

    Read more
  • Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    11/28 03:44 pm

    Benzinga

    Read more
  • What 5 Analyst Ratings Have To Say About Acelyrin

    11/28 09:00 am

    Benzinga

    Read more
  • ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program

    11/27 05:30 pm

    GlobeNewswire Inc.

    Read more
  • Acelyrin (SLRN) Q3 2023 Earnings Call Transcript

    11/07 10:45 pm

    The Motley Fool

    Read more
  • ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights

    11/07 05:05 pm

    GlobeNewswire Inc.

    Read more
  • ACELYRIN, INC. to Report Third Quarter 2023 Financial Results and Corporate Update on November 7, 2023

    10/31 04:30 pm

    GlobeNewswire Inc.

    Read more
  • Why Acelyrin Stock Plummeted 59% This Week

    09/15 05:39 pm

    The Motley Fool

    Read more
  • Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    09/13 02:07 pm

    Benzinga

    Read more
  • Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023

    09/13 11:00 am

    Benzinga

    Read more
  • ACELYRIN (SLRN) Fails to Meet Goal in HS Study, Stock Down 54%

    09/13 09:45 am

    Zacks Investment Research

    Read more
  • Despite Trial Setback For Acelyrin's Lead Program, Analyst Shows Optimism

    09/12 02:57 pm

    Benzinga

    Read more
  • Crude Oil Rises 2%; Avalo Therapeutics Shares Spike Higher

    09/12 02:44 pm

    Benzinga

    Read more
  • Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    09/12 01:44 pm

    Benzinga

    Read more
  • Dow Turns Higher; Oracle Shares Tumble After Q1 Results

    09/12 12:10 pm

    Benzinga

    Read more
  • Why Shares of MoonLake Immunotherapeutics Are Rising Tuesday

    09/12 11:40 am

    The Motley Fool

    Read more
  • Dow Falls 75 Points; US Small Business Optimism Drops In August

    09/12 09:59 am

    Benzinga

    Read more
  • Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

    09/12 08:00 am

    Benzinga

    Read more
  • Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

    09/12 05:40 am

    Benzinga

    Read more
  • ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa

    09/11 04:05 pm

    GlobeNewswire Inc.

    Read more
  • ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

    09/06 07:00 am

    GlobeNewswire Inc.

    Read more
  • Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023

    09/05 11:00 am

    Benzinga

    Read more
  • Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts

    08/31 01:38 pm

    Benzinga

    Read more
  • Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday

    08/15 10:42 am

    Benzinga

    Read more
  • Acelyrin (SLRN) Q2 2023 Earnings Call Transcript

    08/14 11:30 pm

    The Motley Fool

    Read more
  • ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights

    08/14 04:05 pm

    GlobeNewswire Inc.

    Read more
  • ACELYRIN, INC. to Present Second Quarter 2023 Financial Results and Corporate Update on August 14, 2023

    08/07 04:30 pm

    GlobeNewswire Inc.

    Read more
  • ACELYRIN, INC. Appoints Ken Lock as Chief Commercial Officer 

    07/18 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    06/27 01:56 pm

    Benzinga

    Read more
  • Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    06/26 12:31 pm

    Benzinga

    Read more
  • Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday

    06/26 10:13 am

    Benzinga

    Read more
  • US Stocks Edge Higher; Goldman Sachs Downgrades Tesla To Neutral

    06/26 09:44 am

    Benzinga

    Read more
  • ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights

    06/15 04:05 pm

    GlobeNewswire Inc.

    Read more
  • Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023

    05/30 11:00 am

    Benzinga

    Read more
  • Wall Street Breakfast: The Week Ahead

    05/28 07:30 am

    Seeking Alpha

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: